NCT00453297View on ClinicalTrials.gov

Phase I Study to Evaluate the Safety and Efficacy of MF101 as Well as the Pharmacokinetics of Its Key Active Components

PHASE1TerminatedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

April 30, 2007

Conditions
Healthy
Interventions
DRUG

MF101

Trial Locations (1)

80012

University of Colorado Health Sciences Center, Aurora

Sponsors

Lead Sponsor

Bionovo
All Listed Sponsors
lead

Bionovo

INDUSTRY

NCT00453297 - Phase I Study to Evaluate the Safety and Efficacy of MF101 as Well as the Pharmacokinetics of Its Key Active Components | Biotech Hunter | Biotech Hunter